SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-21-150588
Filing Date
2021-12-16
Accepted
2021-12-16 17:23:40
Documents
2
Group Members
BAKER BROS. ADVISORS (GP) LLCFELIX J. BAKERJULIAN C. BAKER

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2135579d1_sc13d.htm SC 13D 114096
2 EXHIBIT 99.1 tm2135579d1_ex99-1.htm EX-99.1 6558
  Complete submission text file 0001104659-21-150588.txt   122414
Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014 2123395600
BAKER BROS. ADVISORS LP (Filed by) CIK: 0001263508 (see all company filings)

IRS No.: 134093645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Subject) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93025 | Film No.: 211498603
SIC: 2834 Pharmaceutical Preparations